David A. Proia

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Michael Hedvat, Dennis Huszar, Andreas Herrmann et al. · Cancer Cell · 2009 · 529 citations · Full text

Medicine, Oncology, Pharmacology +9

Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment

Evguenia M. Alexandrova, Alisha R. Yallowitz, Dun Li et al. · Nature · 2015 · 366 citations · Full text

Medicine, Cancer Biology, Oncology +14

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 231 citations

Medicine, Oncology, Pharmacology +11

Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Jim Sang, Jaime Acquaviva, Julie C. Friedland et al. · Cancer Discovery · 2013 · 210 citations

Medicine, Oncology, Pharmacology +17

Systemic Stromal Effects of Estrogen Promote the Growth of Estrogen Receptor–Negative Cancers

Piyush B. Gupta, David A. Proia, Oya Cingöz et al. · Cancer Research · 2007 · 175 citations

Medicine, Endocrinology, Oncology +17